Stay updated on Ziftomenib in AML Clinical Trial
Sign up to get notified when there's something new on the Ziftomenib in AML Clinical Trial page.

Latest updates to the Ziftomenib in AML Clinical Trial page
- ChecktodayChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the page history.SummaryDifference0.0%

- Check7 days agoChange DetectedRevision: v3.4.3 has been added as the latest update, replacing the previous v3.4.2 entry.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedAdded Revision: v3.4.2 and removed the funding/operating-status notice as well as Revision: v3.4.1 from the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedAdded a government funding notice banner noting potential data delays and that the NIH Clinical Center is open. Updated the page revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check50 days agoChange DetectedThe history page adds a glossary toggle and color-coded change explanations, and removes the No FEAR Act data note while updating the revision to v3.4.0.SummaryDifference0.5%

- Check64 days agoChange DetectedRevision labels in the history were updated with v3.3.4 added and v3.3.3 removed, which are administrative changes to the history log. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Ziftomenib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ziftomenib in AML Clinical Trial page.